Cormedix Inc. Announces Resubmission of New Drug Application for Defencath
CorMedix Inc. announced that the New Drug Application for DefenCath was resubmitted to the U.S. Food and Drug Administration, and the submission has been acknowledged as received for processing.... | May 17, 2023
Drug Administration Cormedix Inc New Drug Application Cormedix Inc Stock Exchange Press Release Or Crmd Us21900c3088
Source: marketscreener.com